<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-320</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АНАЛИТИЧЕСКИЕ МЕТОДИКИ И МЕТОДЫ КОНТРОЛЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ANALYTICAL AND QUALITY CONTROL METHODS</subject></subj-group></article-categories><title-group><article-title>СТАНДАРТИЗАЦИЯ ФАРМАЦЕВТИЧЕСКОЙ СУБСТАНЦИИ КАТИОННОГО ПРОИЗВОДНОГО БАКТЕРИОПУРПУРИНИМИДА ДЛЯ АНТИМИКРОБНОЙ ФОТОДИНАМИЧЕСКОЙ ТЕРАПИИ</article-title><trans-title-group xml:lang="en"><trans-title>STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolova</surname><given-names>A. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Графов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Grafov</surname><given-names>D. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюкова</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tukova</surname><given-names>V. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ворфоломеева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorfolomeeva</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирьянов</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Keryanov</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филоненко</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Feelonenko</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Panov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грин</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Green</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кедик</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kedeek</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский химико-технологический университет (РХТУ) им. Д. И. Менделеева</institution></aff><aff xml:lang="en"><institution>D. Mendeleev University of Chemical Technology of Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Московский технологический университет (МИТХТ) ЗАО «Институт фармацевтических технологий»</institution></aff><aff xml:lang="en"><institution>Technological university of Moscow Limited company «Institute of pharmaceutical technology»; &#13;
LLC «Institute of pharmaceutical technology»</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Московский научно-исследовательский онкологический институт (МНИОИ) им. П.А. Герцена</institution></aff><aff xml:lang="en"><institution>P. Gercen scientific-research oncological institute of Moscow</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ЗАО «Институт фармацевтических технологий»</institution></aff><aff xml:lang="en"><institution>Limited company «Institute of pharmaceutical technology»</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>01</month><year>2019</year></pub-date><volume>0</volume><issue>1</issue><fpage>94</fpage><lpage>102</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фролова А.М., Графов Д.А., Тюкова В.С., Ворфоломеева Е.В., Кирьянов Н.А., Филоненко Е.В., Панов А.В., Грин М.А., Кедик С.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Фролова А.М., Графов Д.А., Тюкова В.С., Ворфоломеева Е.В., Кирьянов Н.А., Филоненко Е.В., Панов А.В., Грин М.А., Кедик С.А.</copyright-holder><copyright-holder xml:lang="en">Frolova A.M., Grafov D.A., Tukova V.S., Vorfolomeeva E.V., Keryanov N.A., Feelonenko E.V., Panov A.V., Green M.A., Kedeek S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/320">https://www.pharmjournal.ru/jour/article/view/320</self-uri><abstract><p>В данной работе представлены основные показатели, регламентируемые Государственной Фармакопеей XIII издания [<xref ref-type="bibr" rid="cit1">1</xref>], которые могут применяться для стандартизации катионного производного бактериопурпуринимида. Анализ данного соединения проводится с целью его последующего использования в качестве фармацевтической субстанции (ФС), преимущественным путём применения которой является антимикробная фотодинамическая терапия (ФДТ).</p></abstract><trans-abstract xml:lang="en"><p>In this paper key indicators due to Pharmacopoeia XIII [<xref ref-type="bibr" rid="cit1">1</xref>] that can be used to standardize the cationic derivative of bakteriopurpurinimid as pharmaceutical substance (PS) are presented. The prime application of this compound to be a photosensitiser for antimicrobial photodynamic therapy (PDT).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>стандартизация</kwd><kwd>контроль качества</kwd><kwd>фармацевтическая субстанция</kwd><kwd>антимикробная фотодинамическая терапия</kwd><kwd>катионное производное</kwd><kwd>бактериопурпуринимид</kwd></kwd-group><kwd-group xml:lang="en"><kwd>standardization</kwd><kwd>quality control</kwd><kwd>pharmaceutical substance</kwd><kwd>antimicrobial photodynamic therapy</kwd><kwd>cationicderivative</kwd><kwd>bakteriopurpurinimid</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Государственная фармакопея РФ, ХIII издание. - М.: ФЭМБ, 2015. 1294 с.</mixed-citation><mixed-citation xml:lang="en">Государственная фармакопея РФ, ХIII издание. - М.: ФЭМБ, 2015. 1294 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">А.Т. Солдатенков, Н.М. Колядина, И.В. Шендрик. Основы органической химии лекарственных веществ. - М.: Мир, 2007. 192 с.</mixed-citation><mixed-citation xml:lang="en">А.Т. Солдатенков, Н.М. Колядина, И.В. Шендрик. Основы органической химии лекарственных веществ. - М.: Мир, 2007. 192 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Практическое руководство по антиинфекционной химиотерапии / Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. - С.: НИИАХ СГМА, 2002. 586 с.</mixed-citation><mixed-citation xml:lang="en">Практическое руководство по антиинфекционной химиотерапии / Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. - С.: НИИАХ СГМА, 2002. 586 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">T. Maisch. A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment // Mini-reviews in Medicinal Chemistry. 2009. V. 9. P. 947-983.</mixed-citation><mixed-citation xml:lang="en">T. Maisch. A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment // Mini-reviews in Medicinal Chemistry. 2009. V. 9. P. 947-983.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">J.M. Lim, Z.S. Yoon, J.-Y. Shin, K.S. Kim, M.-C. Yoon, D. Kim. The photophysical properties of expanded porphyrins: relationships between aromaticity, molecular geometry and non-linear optical properties // Chemical Communications. 2008. V. 3.</mixed-citation><mixed-citation xml:lang="en">J.M. Lim, Z.S. Yoon, J.-Y. Shin, K.S. Kim, M.-C. Yoon, D. Kim. The photophysical properties of expanded porphyrins: relationships between aromaticity, molecular geometry and non-linear optical properties // Chemical Communications. 2008. V. 3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">А.И. Нетрусов, И.Б. Котова. Микробиология. 3-е изд., испр. - М.: Академия, 2009. 352 с.</mixed-citation><mixed-citation xml:lang="en">А.И. Нетрусов, И.Б. Котова. Микробиология. 3-е изд., испр. - М.: Академия, 2009. 352 с.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">T. Dai, Y.-Y. Huang, M. Hamblin. Photodynamic therapy for localized infections - state of the art // Photodiagnosis and Photodynamic Therapy. 2009. V. 6. P. 170-188.</mixed-citation><mixed-citation xml:lang="en">T. Dai, Y.-Y. Huang, M. Hamblin. Photodynamic therapy for localized infections - state of the art // Photodiagnosis and Photodynamic Therapy. 2009. V. 6. P. 170-188.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">М.Г. Страховская, Н.С. Беленикина, В.В. Никитина, С.Ю. Коваленко, И.Б. Коваленко, А.В. Аверьянов, А.Б. Рубин. Перспективный фотосенсибилизатор для антимикробной фотодинамической терапии // Клиническая практика. 2013. № 1. С. 25-30.</mixed-citation><mixed-citation xml:lang="en">М.Г. Страховская, Н.С. Беленикина, В.В. Никитина, С.Ю. Коваленко, И.Б. Коваленко, А.В. Аверьянов, А.Б. Рубин. Перспективный фотосенсибилизатор для антимикробной фотодинамической терапии // Клиническая практика. 2013. № 1. С. 25-30.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">X. Ragàs, D. Sánchez-García, R. Ruiz-González, T. Dai, M. Agut, R. Hamblin, S. Nonell Cationic. Porphycenes as Potential Photosensitizers for Antimicrobial Photodynamic Therapy //Journal of Medical Chemistry. 2010. V. 53. P. 7796-7803.</mixed-citation><mixed-citation xml:lang="en">X. Ragàs, D. Sánchez-García, R. Ruiz-González, T. Dai, M. Agut, R. Hamblin, S. Nonell Cationic. Porphycenes as Potential Photosensitizers for Antimicrobial Photodynamic Therapy //Journal of Medical Chemistry. 2010. V. 53. P. 7796-7803.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
